Search by Drug Name or NDC

    NDC 50488-0901-01 Laxacin 50; 8.6 mg/1; mg/1 Details

    Laxacin 50; 8.6 mg/1; mg/1

    Laxacin is a ORAL TABLET in the HUMAN OTC DRUG category. It is labeled and distributed by Alexso, Inc.. The primary component is DOCUSATE SODIUM; SENNOSIDES A AND B.

    Product Information

    NDC 50488-0901
    Product ID 50488-0901_b2618d56-dcea-489a-949d-3d16d63d504d
    Associated GPIs 46991002770320
    GCN Sequence Number 048044
    GCN Sequence Number Description sennosides/docusate sodium TABLET 8.6MG-50MG ORAL
    HIC3 D6S
    HIC3 Description LAXATIVES AND CATHARTICS
    GCN 13483
    HICL Sequence Number 021772
    HICL Sequence Number Description SENNOSIDES/DOCUSATE SODIUM
    Brand/Generic Generic
    Proprietary Name Laxacin
    Proprietary Name Suffix n/a
    Non-Proprietary Name Docusate sodium and sennosides
    Product Type HUMAN OTC DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 50; 8.6
    Active Ingredient Units mg/1; mg/1
    Substance Name DOCUSATE SODIUM; SENNOSIDES A AND B
    Labeler Name Alexso, Inc.
    Pharmaceutical Class n/a
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH NOT FINAL
    Application Number part334
    Listing Certified Through 2024-12-31

    Package

    NDC 50488-0901-01 (50488090101)

    NDC Package Code 50488-0901-1
    Billing NDC 50488090101
    Package 100 TABLET in 1 BOTTLE (50488-0901-1)
    Marketing Start Date 2018-10-15
    NDC Exclude Flag N
    Pricing Information N/A
    << 50488-0410-01 50488-1001-01 >>

    Contents

    Standard Product Labeling (SPL)/Prescribing Information SPL 0df9abaf-3997-4dde-8003-ae3d8d07cf39 Details

    Revised: 1/2022
    Document Id: b2618d56-dcea-489a-949d-3d16d63d504d
    Set id: 0df9abaf-3997-4dde-8003-ae3d8d07cf39
    Version: 7
    Effective Time: 20220120